Relfydess: A New Era in Wrinkle Relaxing Treatments in 2025
- Juvenology Clinic
- Apr 8, 2025
- 8 min read
Updated: Apr 8
I have a particular kind of professional obsession with variables.
It started in the Cardiac Catheterisation Laboratory at KIMS Hospital. In that environment, inconsistency wasn't an inconvenience. It was a patient safety issue. The dilution of a medication, the timing of an intervention, the technique applied on a Tuesday versus a Friday, these things mattered in ways that were immediately and measurably consequential. You controlled every variable you could control because the ones you couldn't control were already enough to worry about.
I carried that mindset into aesthetic medicine when I founded Juvenology in 2016. And one of the variables I have thought about more than most practitioners acknowledge is botulinum toxin reconstitution.
Every conventional botulinum toxin product arrives as a lyophilised powder. Before it reaches a patient, it must be reconstituted with saline. The dilution ratio, the technique, the timing, the storage conditions after mixing, all of these affect the final product. Two practitioners using the same powder product in different clinics on different days are not necessarily administering an identical solution. Most patients never think about this. I think about it constantly.
Relfydess changes it entirely. And that, for a practitioner who thinks the way I do, is genuinely significant.
What PEARL technology actually means
PEARL stands for Precipitation-free Extraction and Activity-preserving Refined Liquid. It is the manufacturing process that produces a complex-free, ready-to-use liquid formulation. Relfydess arrives as a liquid. No reconstitution. No dilution ratio to calculate. No variability introduced by mixing technique or storage time after preparation.
The complexing proteins removed in this process deserve a mention. Conventional botulinum toxin products carry proteins that accompany the active molecule but contribute nothing to the treatment effect. Their presence, however, may increase immunogenicity, the likelihood of the body developing antibodies that could reduce treatment efficacy over repeated sessions. Removing them is not just a manufacturing convenience. It is a clinically relevant decision.
What this means for a practitioner trained to value precision: every dose is the same. Every vial is consistent. The variables that exist with reconstituted products simply do not exist here. For patients, that translates to more predictable, reproducible outcomes from one appointment to the next. For me, it removes a source of variability I have always been uncomfortable leaving uncontrolled.
What the READY trials actually found
The clinical programme for Relfydess, known as the READY trials, is one of the largest Phase 3 programmes conducted for a botulinum toxin neuromodulator, involving over 1,900 participants across multiple studies evaluating frown lines and crow's feet. I want to walk through the numbers carefully because they are meaningfully different from what we see in existing products.
The READY-1 trial, published in the Aesthetic Surgery Journal in November 2024, was a double-blind, randomised, placebo-controlled Phase 3 study in 297 participants evaluating glabellar lines. The headline findings:
82.9% of participants achieved a two-grade or greater improvement at one month, compared to 0% in the placebo group
96.3% had none or mild frown lines at maximum contraction at peak effect
39% saw measurable improvement from day one
75% had not returned to baseline wrinkle severity at 169 days, approximately five and a half months
The day one figure is the one I find most clinically interesting. Most existing neuromodulators don't demonstrate that. The duration figure matters too. Three to four months is the standard expectation for conventional products. Seventy-five percent of participants still below baseline at nearly six months is a meaningful difference.
The patient experience data is, if anything, more compelling than the efficacy numbers. A patient-reported outcomes paper from the READY-1 study, published in the Aesthetic Surgery Journal in July 2025, found that more than 83% of participants reported natural-looking results and more than 75% felt confident making expressions. Patient satisfaction remained consistent across the full six-month follow-up period.
That last detail is the one I keep returning to. Confidence in making natural facial expressions is not a cosmetic vanity metric. It is a measure of whether a treatment has done what good aesthetic medicine is supposed to do: help someone feel like themselves. When that confidence holds for six months, that is a result worth noting.
The Phase 3 READY-4 long-term safety trial, involving over 900 participants across multiple treatment cycles over twelve months, confirmed that efficacy and patient satisfaction were maintained across repeated treatments, with a safety profile consistent with the earlier READY-1, 2, and 3 studies. The safety data is reassuring. The consistency data is what I find most relevant.
What this means in practice
I want to be precise about what Relfydess changes and what it does not, because precision is exactly the point.
What changes: reconstitution variability is eliminated. Dosing consistency is improved. Onset is demonstrably rapid, with results measurable from day one in a significant proportion of patients. Duration of effect in trials extends up to six months for many patients, longer than the typical three to four months cited for conventional products.
What does not change: the anatomy of your face. The need for individual assessment before every treatment. The importance of adjusted dosing based on your specific muscle strength, asymmetries, and treatment history. The fact that brow position, facial balance, and expression preservation all depend on the practitioner's anatomical knowledge and clinical judgement, not the product alone.
Technology improves consistency. Skill determines outcomes. A ready-to-use formulation reduces one source of variability in the treatment process. It does not replace the consultation, the mapping, the measurement, or the two-week review that distinguishes careful, evidence-based anti-wrinkle treatment from a rushed appointment with identical dosing for every patient.
What Relfydess treats and what it does not
Botulinum toxin treats dynamic wrinkles: lines caused by repeated muscle movement. Frown lines between the brows, crow's feet around the eyes, forehead lines, and certain lower face concerns including downturned mouth corners and chin dimpling all respond well to precise, conservative neuromodulator treatment.
It does not treat volume loss, for which dermal fillers are the appropriate tool. It does not address skin laxity, for which PDO threads or HIFU address the structural causes. It does not improve skin quality, for which polynucleotides, Profhilo, or PRP are more appropriate. And it does not significantly affect static wrinkles, lines present at rest without muscle movement, which require a different approach.
Understanding which concern requires which treatment is the foundation of a genuinely useful consultation. It is why I discuss the full picture at every appointment rather than simply treating what a patient arrives asking about.
A note on UK regulation
Botulinum toxin is a prescription-only medicine in the UK. As the MHRA has confirmed, it must be sold and supplied only in accordance with a prescription from an appropriate prescriber. This applies to Relfydess as it does to every botulinum toxin product.
The JCCP has published guidance stating that patients should receive a face-to-face consultation with a prescribing professional before any botulinum toxin procedure. That is the standard at Juvenology. Always has been. The regulatory landscape is simply catching up with what good clinical practice already required.
Frequently asked questions
Is Relfydess available at Juvenology? Yes. It is part of the treatment options offered at Juvenology Clinic in Maidstone. Which specific product is used for your treatment is discussed as part of your full consultation, where individual needs, anatomy, and treatment history are all assessed before any decision is made.
How long does Relfydess last? Clinical trials demonstrate results lasting up to six months in many patients, with 75% of READY-1 participants not returning to baseline at 169 days. Individual response varies and duration is influenced by factors including muscle strength, metabolism, and treatment history.
Does the ready-to-use formulation make a difference to patients? It improves consistency between appointments. Because there is no reconstitution step, the product each patient receives is identical from one visit to the next, reducing a source of variability that exists with conventional powder-based products.
What is PEARL technology? PEARL stands for Precipitation-free Extraction and Activity-preserving Refined Liquid. It is the manufacturing process that produces a complex-free, ready-to-use liquid formulation, removing the complexing proteins present in conventional botulinum toxin products that do not contribute to treatment effect but may affect immunogenicity over time.
How is this different from other botulinum toxins? Existing products such as Botox (onabotulinumtoxinA) and Azzalure (abobotulinumtoxinA) arrive as lyophilised powder and require reconstitution before use. Relfydess is the first product in this class to arrive as a ready-to-use liquid, removing the reconstitution variable and providing volumetric dosing precision. The clinical evidence also demonstrates a notably rapid onset and duration of up to six months.
Book your anti-wrinkle consultation at Juvenology, Maidstone
In cardiac nursing, I learned that the best technology in the world still depends on the person using it. Relfydess is a genuine step forward in formulation science. The elimination of reconstitution variability matters. The trial data is robust. The duration and onset figures are meaningfully better than what we see in conventional products.
But it does not change the fundamentals of what good aesthetic practice requires.
Individual assessment. Anatomical precision. Conservative dosing. A mandatory review.
Honest communication about what a treatment can and cannot achieve. Those fundamentals are what I brought from cardiac nursing into aesthetics in 2016, and no product, however well-engineered, replaces them.
About the author
Nurse Marina is an aesthetic nurse specialist based in Maidstone, Kent, with over 25 years of nursing experience including cardiac care at KIMS Hospital. She leads Juvenology Clinic with a commitment to anatomical precision, evidence-based practice, and compassionate patient care. Marina is NMC Registered, BACN Member, JCCP Verified, ACE Group Registered, and a Member of the Royal College of Nursing.
From anti-wrinkle injections and dermal fillers to advanced regenerative treatments and longevity medicine, Marina combines rigorous medical knowledge with a nurturing, patient-centred approach.
Further reading on anti-wrinkle treatments
If this article has raised questions about what careful anti-wrinkle treatment involves beyond the product itself, these posts go deeper on the anatomy, the technique, and what to look for in a practitioner.
One Eyebrow Higher After Treatment: Brow Asymmetry Explained The most common complication patients bring to me after anti-wrinkle treatment elsewhere. This article explains the anatomy behind why it happens, how it is corrected, and what careful technique does to prevent it before it starts.
Managing Forehead Heaviness After Botox The other side of the same coin. Forehead heaviness after anti-wrinkle treatment is a direct consequence of the same anatomical system described in this article — the frontalis as the sole brow elevator. What causes it, what resolves it, and what it tells you about the treatment you received.
Lower Face Botox in Maidstone Relfydess, like all botulinum toxin products, treats more than frown lines and crow's feet. This article covers the lower face applications — jaw, chin, downturned mouth corners and what precise, conservative dosing looks like in a more anatomically complex region.
Masseter Botox For patients interested in jaw slimming or teeth grinding treatment, this article covers how botulinum toxin works in the masseter, what results look like when dosing is correct, and why individual muscle assessment matters as much here as it does at the brow.
Related services at Juvenology
Anti-Wrinkle Injections The service this article is written to support. If you are considering anti-wrinkle treatment, or want to discuss whether Relfydess is appropriate for your anatomy and treatment history, a consultation at Juvenology starts with a full individual assessment before any decision is made about product or dosing.
Dermal Fillers As this article explains, botulinum toxin treats dynamic wrinkles caused by muscle movement. Volume loss requires a different tool. For patients whose concerns involve both, a combined approach using anti-wrinkle treatment alongside filler is often the more complete solution.
Profhilo For patients whose skin quality concerns go beyond muscle movement, laxity, hydration, texture. Profhilo addresses the dermal layer that botulinum toxin does not reach. Often used as part of a staged protocol alongside anti-wrinkle treatment for a more complete result.
Polynucleotides Where Relfydess addresses muscle activity and Profhilo addresses hydration, polynucleotides work at the level of cellular regeneration, stimulating fibroblast activity and tissue repair from within. For patients interested in the most comprehensive skin health approach, polynucleotides are often the next conversation after anti-wrinkle treatment is established.
Not sure where to start?
If you are considering anti-wrinkle treatment for the first time, or want to review your current treatment with a practitioner who thinks carefully about product, dosing, and individual anatomy, a consultation at Juvenology is the most useful next step. We will assess your concerns, your facial anatomy, and your treatment history before recommending anything.
We see patients from across Kent including Maidstone, Tonbridge, Sevenoaks, Kings Hill, West Malling, Medway, and Chatham.